Orchid Cellmark awarded U.K. national scrapie plan genotyping contract
Orchid Cellmark Inc. announced that the U.K. government has extended the company's scrapie genotyping contract through 2007 and 2008. The extension is expected to be worth in excess of $3.5 million annually. Under the terms of the agreement, Orchid Cellmark will become the exclusive supplier of Genotyping services offered to sheep farmers under the government's National Scrapie Plan for Great Britain, which is designed to help British farmers breed sheep with reduced genetic susceptibility to the prion disease scrapie.
The contract renewal is part of the National Scrapie Plan for Great Britain developed by the Department for Environment, Food and Rural Affairs (DEFRA) in conjunction with the Agriculture and Rural Affairs Departments in Scotland and Wales. The voluntary National Scrapie Plan is a long-term initiative of the U.K. government to eradicate scrapie from the national flock and thereby reduce the economic costs and potential risk to the sheep industry posed by sheep with scrapie. Orchid Cellmark's genotyping service has analyzed the DNA of approximately two million sheep under this program since 2001.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.